Full name
"PHARMALAND MEDICAMENTI" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,7 | 0,1 | -4,8 | -4896 |
EBITDA | 1 | 0,4 | -4,2 | -1208,1 |
Short time liabilities | 5 | 5,1 | 8,5 | 64,7 |
Equity capital | -1,3 | -1,2 | -4 | -242,2 |
Operating profit (EBIT) | 0,9 | 0,3 | -4,5 | -1591 |
Assets | 3,8 | 4 | 10,2 | 155,8 |
Net profit (loss) | 0,7 | 0,1 | -4,8 | -4896 |
Cash | 0,2 | 0,1 | 1,8 | 1524,4 |
Net income from sale | 21 | 24,6 | 19,1 | -22,7 |
Liabilities and provisions for liabilities | 5,1 | 5,2 | 14,3 | 175,5 |
Working assets | 3,3 | 3,6 | 9,3 | 160,6 |
Depreciation | 0,1 | 0,1 | 0,3 | 317 |
% | % | % | p.p. | |
Profitability of capital | -56,7 | -8,5 | 118,8 | 127,3 |
Equity capital to total assets | -33,7 | -29,5 | -39,5 | -10 |
Gross profit margin | 3,5 | 0,4 | -25,2 | -25,6 |
EBITDA Margin | 4,5 | 1,5 | -22 | -23,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 86 | 76 | 162 | 86 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane